REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novo S.A. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novo S.A. Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Novo S.A. is a Polish company headquartered in Tychy, Poland. Established on July 15, 2010, Novo S.A. operates in the pharmaceutical and medicine manufacturing industry. The company focuses on producing drugs and druggists' sundries, serving as a merchant wholesaler1. Novo S.A. employs around 200 people and has reported steady growth in net sales revenue and total assets.

Headquarters
Ul. Mikolowska 232
Tychy; Slaskie; Postal Code: 43-100

Contact Details: Purchase the Novo S.A. report to view the information.

Website: http://novo-sa.pl/

Basic Information
Total Employees:
Purchase the Novo S.A. report to view the information.
Outstanding Shares:
Purchase the Novo S.A. report to view the information.
Registered Capital:
Purchase the Novo S.A. report to view the information.
Financial Auditors:
Purchase the Novo S.A. report to view the information.
Incorporation Date:
July 15, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Novo S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
1.75%▲
Total operating revenue
1.75%▲
Operating profit (EBIT)
10.54%▲
EBITDA
8.98%▲
Net Profit (Loss) for the Period
8.61%▲
Total assets
15.01%▲
Total equity
8.36%▲
Operating Profit Margin (ROS)
0.14%▲
Net Profit Margin
0.08%▲
Return on Equity (ROE)
0.05%▲
Debt to Equity Ratio
15.71%▲
Quick Ratio
-0.04%▼
Cash Ratio
0%

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Lek S.A.
Bayer Sp. z o.o.
 
"Roche Polska" Sp. z o.o.
Teva Operations Poland Sp. z o.o.
 
Adamed Pharma S.A.
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
 
Warszawskie Zaklady Farmaceutyczne Polfa S.A. Skrot: Warszawskie Zaklady Farmaceutyczne Polfa S.A. Polfa Warszawa S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
"Anpharm" Przedsiebiorstwo Farmaceutyczne S.A.
Servier Polska Services Sp. z o.o.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo